Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Director · Executive Chairman | January 02, 2026 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date January 02, 2026 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 238,462 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Tax withholding · Disposed 2,171 · Balance 238,462 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2021 Filed Jun 4, 2021 01:23 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 26,504 | $63.75 | $1,689,526.63 |
DisclosureSEC source: 0001179110-21-006399 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,496 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.09 to $63.9975 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) (4), (5), (6) and (7). Read SEC document |
| June 01, 2021 Filed Jun 4, 2021 01:23 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-21-006399 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2021 Filed May 7, 2021 23:36 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-005030 · edgar.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,134,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| May 05, 2021 Filed May 7, 2021 23:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 514 | $53.30 | $27,396.20 |
DisclosureSEC source: 0001179110-21-005030 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.02 to $54.14 inclusive. Read SEC document |
| May 05, 2021 Filed May 7, 2021 23:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 40,573 | $53.30 | $2,162,540.90 |
DisclosureSEC source: 0001179110-21-005030 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.98 inclusive. Read SEC document |
| May 05, 2021 Filed May 7, 2021 23:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,913 | $52.78 | $470,428.14 |
DisclosureSEC source: 0001179110-21-005030 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,087 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.40 to $52.9950 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4). Read SEC document |
| May 05, 2021 Filed May 7, 2021 23:36 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-21-005030 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2021 Filed May 5, 2021 21:58 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-004917 · edgar.xml · derivative · entry 10 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,184,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| May 04, 2021 Filed May 5, 2021 21:58 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 36,056 | $54.33 | $1,958,922.48 |
DisclosureSEC source: 0001179110-21-004917 · edgar.xml · nonDerivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.90 inclusive. Read SEC document |
| May 04, 2021 Filed May 5, 2021 21:58 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 13,944 | $53.83 | $750,605.52 |
DisclosureSEC source: 0001179110-21-004917 · edgar.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,056 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.31 to $53.99 inclusive. Read SEC document |
| May 04, 2021 Filed May 5, 2021 21:58 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-21-004917 · edgar.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:58 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-004917 · edgar.xml · derivative · entry 9 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,234,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:58 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 501 | $57.47 | $28,792.47 |
DisclosureSEC source: 0001179110-21-004917 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.45 to $57.50 inclusive. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:58 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,651 | $56.18 | $486,013.18 |
DisclosureSEC source: 0001179110-21-004917 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 501 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.00 to $56.90 inclusive. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:58 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 40,848 | $55.69 | $2,274,825.12 |
DisclosureSEC source: 0001179110-21-004917 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,152 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.22 to $55.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6). Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:58 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-21-004917 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 23:18 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 36,676 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-004368 · edgar.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,284,384 Underlying: Common Stock · 36,676 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 23:18 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 36,676 | $45.58 | $1,671,692.08 |
DisclosureSEC source: 0001179110-21-004368 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.52 to $45.82 inclusive. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 23:18 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 36,676 | $0.91 | $33,375.16 |
DisclosureSEC source: 0001179110-21-004368 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 23:18 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 300 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-004368 · edgar.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,321,060 Underlying: Common Stock · 300 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 23:18 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 300 | $45.78 | $13,734.00 |
DisclosureSEC source: 0001179110-21-004368 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.74 to $45.87 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 23:18 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 300 | $0.91 | $273.00 |
DisclosureSEC source: 0001179110-21-004368 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 06, 2021 Filed Apr 7, 2021 20:27 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 77,590 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-004309 · edgar.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,321,360 Underlying: Common Stock · 77,590 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| April 06, 2021 Filed Apr 7, 2021 20:27 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 77,590 | $46.10 | $3,576,899.00 |
DisclosureSEC source: 0001179110-21-004309 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.92 to $46.32 inclusive. Read SEC document |
| April 06, 2021 Filed Apr 7, 2021 20:27 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 77,590 | $0.91 | $70,606.90 |
DisclosureSEC source: 0001179110-21-004309 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,590 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 20:27 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 34,430 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-004309 · edgar.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,398,950 Underlying: Common Stock · 34,430 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 20:27 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 34,430 | $46.10 | $1,587,223.00 |
DisclosureSEC source: 0001179110-21-004309 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.07 to $46.35 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in in footnotes (2) and (3). Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 20:27 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 34,430 | $0.91 | $31,331.30 |
DisclosureSEC source: 0001179110-21-004309 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:12 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,004 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-004187 · edgar.xml · derivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,433,380 Underlying: Common Stock · 1,004 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:12 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,004 | $46.19 | $46,374.76 |
DisclosureSEC source: 0001179110-21-004187 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.18 to $46.28 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:12 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 1,004 | $0.91 | $913.64 |
DisclosureSEC source: 0001179110-21-004187 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 13, 2021 01:01 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 55,430 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-003392 · edgar.xml · derivative · entry 10 Schlanger David J · CIK 0001576145 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,434,384 Underlying: Common Stock · 55,430 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 12, 2021 Filed Mar 13, 2021 01:01 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 55,430 | $47.57 | $2,636,805.10 |
DisclosureSEC source: 0001179110-21-003392 · edgar.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.37 to $47.92 inclusive. Read SEC document |
| March 12, 2021 Filed Mar 13, 2021 01:01 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 55,430 | $0.91 | $50,441.30 |
DisclosureSEC source: 0001179110-21-003392 · edgar.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 13, 2021 01:01 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 81,567 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-003392 · edgar.xml · derivative · entry 9 Schlanger David J · CIK 0001576145 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,489,814 Underlying: Common Stock · 81,567 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 11, 2021 Filed Mar 13, 2021 01:01 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 81,567 | $47.31 | $3,858,934.77 |
DisclosureSEC source: 0001179110-21-003392 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.27 to $47.54 inclusive. Read SEC document |
| March 11, 2021 Filed Mar 13, 2021 01:01 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 81,567 | $0.91 | $74,225.97 |
DisclosureSEC source: 0001179110-21-003392 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2021 Filed Mar 13, 2021 01:01 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,003 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-003392 · edgar.xml · derivative · entry 8 Schlanger David J · CIK 0001576145 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,571,381 Underlying: Common Stock · 13,003 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 10, 2021 Filed Mar 13, 2021 01:01 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 13,003 | $47.50 | $617,642.50 |
DisclosureSEC source: 0001179110-21-003392 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.23 to $47.94 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in in footnotes (2) and (3). Read SEC document |
| March 10, 2021 Filed Mar 13, 2021 01:01 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 13,003 | $0.91 | $11,832.73 |
DisclosureSEC source: 0001179110-21-003392 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 00:30 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001209191-21-007530 · doc4.xml · derivative · entry 15 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,584,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 00:30 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 500 | $49.40 | $24,700.00 |
DisclosureSEC source: 0001209191-21-007530 · doc4.xml · nonDerivative · entry 11 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.23 to $49.45 inclusive. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 00:30 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,575 | $48.59 | $416,659.25 |
DisclosureSEC source: 0001209191-21-007530 · doc4.xml · nonDerivative · entry 10 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.19 to $49.115 inclusive. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 00:30 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 40,925 | $47.66 | $1,950,485.50 |
DisclosureSEC source: 0001209191-21-007530 · doc4.xml · nonDerivative · entry 9 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,075 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.20 to $48.165 inclusive. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 00:30 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001209191-21-007530 · doc4.xml · nonDerivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 00:30 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001209191-21-007530 · doc4.xml · derivative · entry 14 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,634,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 00:30 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 579 | $49.23 | $28,504.17 |
DisclosureSEC source: 0001209191-21-007530 · doc4.xml · nonDerivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.15 to $49.25 inclusive. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 00:30 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 27,743 | $48.63 | $1,349,142.09 |
DisclosureSEC source: 0001209191-21-007530 · doc4.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 579 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.15 to $49.145 inclusive. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 00:30 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 21,678 | $47.61 | $1,032,089.58 |
DisclosureSEC source: 0001209191-21-007530 · doc4.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,322 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.15 to $48.14 inclusive. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 00:30 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001209191-21-007530 · doc4.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.